首页> 外文期刊>Journal of clinical laboratory analysis. >Application of multiplex methylated‐specific PCR with capillary electrophoresis to explore prognostic value of TSGs hypermethylation for hepatocellular carcinoma
【24h】

Application of multiplex methylated‐specific PCR with capillary electrophoresis to explore prognostic value of TSGs hypermethylation for hepatocellular carcinoma

机译:多重甲基化特异性PCR结合毛细管电泳技术探讨TSGs超甲基化对肝细胞癌的预后价值

获取原文
           

摘要

Background Hepatocellular carcinoma (HCC) is a malignant tumor that severely threatens human health. To date, early detection for HCC patients is particularly significant due to their poor survival rates even after liver resection. Methods Therefore, an efficient and sensitive detection method for monitoring liver cancer, multiplex methylation‐specific PCR (MSP) coupled with capillary electrophoresis, is developed. Results Simulations demonstrated that the methylation status of RASSF1A , p16 , SFRP1 , and ELF could be detected even when DNA equaled or exceeded 12.5?ng simultaneously. Also, its accuracy for methylation detection outweighed polyacrylamide gel electrophoresis (87.5%) and agarose electrophoresis (84.3%), reaching 92.1%. Subsequently, we implemented multiplex MSP with capillary electrophoresis to investigate methylation status of the four tumor suppressor genes in tissue specimens and explore the prognostic value for HCC patients. As the data suggested, multivariate cox regression analysis revealed that the recurrence‐free survival of 46 patients was greatly associated with portal vein tumor thrombus (PVTT) and p16 methylation and receiver operating characteristic (ROC) curves demonstrated that the predictive range of portal vein tumor thrombus (PVTT) combined with p16 hypermethylation was more sensitive than that of either PVTT or p16 hypermethylation alone with regard to disease recurrence in patients with HCC, which could be testified as a valuable biomarker in Clinical application. Conclusion Multiplex MSP coupled with capillary electrophoresis has an excellent prospect of clinical application for monitoring early liver cancer and screening valuable biomarkers for prognosis of HCC patients.
机译:背景肝细胞癌(HCC)是严重威胁人类健康的恶性肿瘤。迄今为止,由于即使在肝切除后存活率也很差,对HCC患者的早期发现尤为重要。方法因此,开发了一种用于监测肝癌的高效灵敏的检测方法,即多重甲基化特异性PCR(MSP)和毛细管电泳。结果仿真表明,即使DNA同时等于或超过12.5ng,也可以检测到RASSF1A,p16,SFRP1和ELF的甲基化状态。而且,其甲基化检测的准确性超过了聚丙烯酰胺凝胶电泳(87.5%)和琼脂糖电泳(84.3%),达到了92.1%。随后,我们实施了带毛细管电泳的多重MSP技术,以研究组织标本中四个抑癌基因的甲基化状态,并探讨对HCC患者的预后价值。如数据所示,多因素cox回归分析显示46例患者的无复发生存率与门静脉肿瘤血栓(PVTT)和p16甲基化及受体工作特征(ROC)曲线密切相关,证明门静脉肿瘤的预测范围就HCC患者的疾病复发而言,血栓(PVTT)联合p16高度甲基化比单独的PVTT或p16高度甲基化更敏感,这可被证明是临床应用中有价值的生物标志物。结论多重MSP结合毛细管电泳在临床早期监测肝癌和筛选有价值的生物标志物对HCC患者的临床应用方面具有广阔的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号